Supplier FDA Compliance
FDA Supplier Compliance Monitoring: Search 483 and Warning Letter History
Pharmaceutical and medical device supply chains depend on contract manufacturers, API suppliers, and CMOs who must maintain their own FDA compliance. This guide explains how to research a supplier's Form 483 history, warning letter record, and inspection classification — and how to build a repeatable monitoring process before onboarding, at renewal, and between audits.
Why supplier FDA compliance monitoring matters
A supplier's FDA compliance record is a leading indicator of supply continuity risk. A facility operating under an active warning letter, with a recent Official Action Indicated (OAI) inspection classification, or with escalating citation frequency across key CFR areas may face import alert risk, production suspension, or consent decree restrictions that directly affect your supply chain.
Internal audits alone are insufficient because they are periodic, access-dependent, and scoped to what the supplier shares. The FDA public record — Form 483 inspection observations, published citations, and warning letters — provides an independent, continuously updated view of the regulatory condition of the facility that internal audits cannot replicate.
What to look for in a supplier's FDA inspection record
When researching a contract manufacturer, API supplier, or CMO in FDA databases, focus on four signal types:
- Form 483 frequency. How many inspections have resulted in observations? A facility that receives Form 483s on most inspection visits has systemic gaps, not isolated events.
- CFR citation patterns. Which regulatory areas repeat across inspections? Recurring observations in the same CFR domain — documentation, CAPA, process validation — indicate that prior corrective actions were ineffective.
- Warning letter history. A warning letter means FDA reviewed the supplier's Form 483 response and found it inadequate. It is a more serious signal than a Form 483 alone.
- Inspection classification. No Action Indicated (NAI), Voluntary Action Indicated (VAI), and Official Action Indicated (OAI) are the three outcomes FDA assigns after each inspection. OAI classifications, especially consecutive ones, are a significant supply risk flag.
How to search FDA supplier records
FDA makes inspection and Form 483 records available through multiple sources:
- FDA Published 483 database. FDA proactively posts Form 483 documents for drug and device inspections. Searchable by company name and FEI number.
- FDA Warning Letters database. Warning letters are publicly posted at fda.gov and searchable by company name, product type, and date range.
- FDA Establishment Inspection Reports (EIRs). Available via FOIA request for completed inspections.
- 483Radar MarketRadar. Searches the stored Published 483 dataset by company name, returning inspection history, linked CFR citations, and warning letter context in one view. Teams can save suppliers to a persistent watchlist and refresh records in bulk when new FDA data is available.
Building a repeatable supplier monitoring process
Point-in-time supplier qualification is not sufficient for high-risk or sole-source suppliers. An effective monitoring process includes:
- Onboarding review. Check Form 483 history, warning letter status, and inspection classification before the first purchase order.
- Annual re-qualification. Re-run the FDA record review at each renewal cycle, not just when an audit is scheduled.
- Event-triggered review. Re-review immediately when FDA publishes a new Form 483 or warning letter for a supplier facility. Don't wait for the next scheduled audit.
- Watchlist monitoring. For critical or sole-source suppliers, use a saved watchlist that surfaces new FDA activity automatically when records are refreshed.
Frequently asked questions
How do I search FDA inspection records for a specific supplier?
FDA publishes records through the Published 483 database and the FOIA Electronic Reading Room. Search by company name or FEI number at fda.gov. 483Radar's MarketRadar feature provides a supplementary search that surfaces inspection rows, citation counts, and warning letter history in a single view.
What is an FEI number?
An FEI number (FDA Establishment Identifier) is a unique identifier FDA assigns to each registered manufacturing establishment. Using an FEI number is more precise than company name search because it resolves ambiguity between facilities with similar names or parent company changes.
What does a supplier warning letter mean for my supply chain?
A warning letter is a formal escalation beyond a Form 483. It means FDA reviewed the supplier's corrective action response and found it inadequate. Supply consequences can include import alert risk, production suspension, and consent decree restrictions. Treat a supplier warning letter as a material compliance event requiring immediate internal escalation.